High-dose ketoconazole to untreated stage D prostate cancer
- 1 March 1988
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 24 (3) , 431-437
- https://doi.org/10.1016/s0277-5379(98)90013-x
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- HYPERTENSION DURING HIGH-DOSE KETOCONAZOLE TREATMENT: A PROBABLE MINERALOCORTICOSTEROID EFFECTThe Lancet, 1987
- Prostate cancer: Evaluation of response to treatment, response criteria, and the need for standardization of the reporting of resultsEuropean Journal of Cancer and Clinical Oncology, 1987
- High-Dose Ketoconazole Therapy in Patients with Metastatic Prostate CancerAmerican Journal of Clinical Oncology, 1986
- Endocrine effects of high-dose ketoconazole therapy in advanced prostatic cancerActa Endocrinologica, 1985
- Effects of single and multiple doses of ketoconazole on adrenal function in normal subjects.British Journal of Clinical Pharmacology, 1985
- KETOCONAZOLE THERAPY FOR ADVANCED PROSTATE CANCERThe Lancet, 1984
- Site of Action of Low Dose Ketoconazole on Androgen Biosynthesis in Men*Journal of Clinical Endocrinology & Metabolism, 1983
- Ketoconazole blocks adrenal steroidogenesis by inhibiting cytochrome P450-dependent enzymes.Journal of Clinical Investigation, 1983
- Ketoconazole Blocks Adrenal Steroid SynthesisAnnals of Internal Medicine, 1982
- Plasma Testosterone: An Accurate Monitor of Hormone Treatment in Prostatic CancerBritish Journal of Urology, 1973